Gabapentin
Product Images NDC 33261-050

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 33261-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

930a0c1e-figure-01 (Gabapentin 400mg Caps Amneal 1)

Chemical structure of Gabapentin shown as a molecular diagram with a cyclohexane ring and functional groups including an amino group and carboxyl group.*

FDA Label Image

930a0c1e-figure-02 (Gabapentin 400mg Caps Amneal 2)

A line graph showing mean pain scores over 8 weeks comparing Gabapentin 3600 mg/day and placebo. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores. Gabapentin shows a decreasing trend in pain scores with significant differences from placebo (p < 0.01).*

FDA Label Image

930a0c1e-figure-03 (Gabapentin 400mg Caps Amneal 3)

A line graph showing mean pain scores over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period followed by a 4-week fixed dose period. Pain scores decrease more with Gabapentin doses compared to placebo.*

FDA Label Image

930a0c1e-figure-04 (Gabapentin 400mg Caps Amneal 4)

A bar graph showing the percentage of responders at endpoint in two studies comparing placebo (PBO) and Gabapentin (GBP) at doses of 1800, 2400, and 3600 mg. Study 1 displays 12% response for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance indicators are included above bars.*

FDA Label Image

930a0c1e-figure-05 (Gabapentin 400mg Caps Amneal 5)

A scatter plot showing the percentage difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin across three studies labeled a, b, and c. The plot uses distinct symbols and shades for each study to compare dosing effects.*

FDA Label Image

Image Label (Gabapentin 400mg Caps Amneal 6)

Gabapentin 100 mg capsule bottle label from Aidarex Pharmaceuticals LLC. The label states a package of 60 capsules, each containing 100 mg of gabapentin. The label includes the NDC 33261-0048-60 and mentions it as a generic version of Neurontin. Manufactured by Amneal Pharmaceuticals of NY, Hauppauge.*

FDA Label Image

Image Label (Gabapentin 400mg Caps Amneal 7)

Gabapentin 300 mg capsule bottle label from Aidarex Pharmaceuticals LLC. The label indicates a package size of 60 capsules. It also shows the active ingredient Gabapentin with a strength of 300 mg per capsule and includes the labeler and manufacturer details along with the NDC number 33261-0049-60.*

FDA Label Image

Image Label (Gabapentin 400mg Caps Amneal 8)

Gabapentin 400 mg capsules packaging label from Aidarex Pharmaceuticals LLC. The label states 30 capsules per bottle, identifies gabapentin as the active ingredient at 400 mg per capsule, and includes the NDC 33261-0050-30. It is marked as generic for Neurontin, with manufacturer information for Aidarex Pharmaceuticals of Hauppauge, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.